Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Henderson, Nevada 89052


Purpose:

This exploratory study is being performed to determine whether a new form formulation of azelaic acid 15% is effective in the treatment of papulopustular rosecea.


Criteria:

Inclusion Criteria: - Papulopustular rosacea with a minimum of 10 and a maximum of 50 papules - Ability and willingness to accept and comply with treatment and required medical examinations Exclusion Criteria: - Known non-responders to azelaic acid - Erythematotelangiectatic, rhinophymatous, ocular, or steroid rosacea - Presence of dermatoses that could interfere with the rosacea diagnosis - Treatment with isotretinoin in the six months prior to randomization - Treatment of the face with topical retinoids during the two weeks prior to randomization - Treatment with oral antibiotics during the four weeks prior to randomization


NCT ID:

NCT00617903


Primary Contact:

Study Chair
Klaus Graupe, PhD
Intendis GmbH


Backup Contact:

N/A


Location Contact:

Henderson, Nevada 89052
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.